1306754-34-6

Upstream product

• 180636-50-4 methyl 4-fluoro-3-methylbenzoate 
• 403-15-6 4-fluoro-3-methyl-benzoic acid 
• 878744-25-3 methyl 3-(bromomethyl)-4-fluorobenzoate 
• 540-38-5 p-Iodophenol 

Downstream Products

• 1306754-22-2 {[3-(4',5'-difluoro-2'-methoxy-biphenyl-4-yloxymethyl)-4-fluoro-benzoyl]-methyl-amino}-acetic acid 
• 1306754-33-5 3-(4',5'-Difluoro-2'-methoxy-biphenyl-4-yloxymethyl)-4-fluoro-benzoic acid 
• 1306754-53-9 {[3-(4',5'-difluoro-2'-methoxy-biphenyl-4-yloxymethyl)-4-fluoro-benzoyl]-methyl-amino}-acetic acid ethyl ester 
• 1310037-04-7 [3-(2',4'-difluorobiphenyl-4-yloxymethyl)-4-fluoro-phenyl]-methanol 
• 1310037-02-5 3-(2',4'-difluorobiphenyl-4-yloxymethyl)-4-fluorobenzoic acid 
• 1310036-96-4 4'-(5-bromomethyl-2-fluoro-benzyloxy)-2,4-difluoro-biphenyl 
• 1310037-00-3 3-(2',4'-difluorobiphenyl-4-yloxymethyl)-4-fluorobenzoic acid methyl ester 

Relevant academic research and scientific papers

BIPHENYL CARBOXYLIC ACIDS AND BIOISOSTERES AS GLYCOGEN SYNTHASE ACTIVATORS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful

NOVEL CARBOXYLIC ACID ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.